194 Chapter 8 A B C D 0 10 20 30 40 Sub-phenotype Number of patients Yes No A B C D 0 10 20 30 40 Sub-phenotype Number of patients A B C D 0 10 20 30 40 Sub-phenotype Number of patients 84-day mortality Persistent SAB day 3 or 7 Persistent SAB day 7 Supplementary Figure 6: Outcomes in the SAFO cohort. Data shown for the SAFO trial control arm participants.
RkJQdWJsaXNoZXIy MTk4NDMw